of 6e. All synthesized compounds were evaluated against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain, finding that some products exhibited good antimycobacterial activity with minimum inhibitory concentration as low as \(3.125\, \upmu \hbox g/mL}\). Docking studies were carried out to identify the binding interactions of compounds II, 6a and 6n with FtsZ. Compounds exhibiting good in vitro
抽象的根据已报道的chroman-4-one药效基团的抗分枝杆菌特性,使用Kabbe缩合方法,从
2-羟基苯乙酮和1,4-dioxaspiroiro [4.5] decan-8-one合成了一系列
化学修饰的双螺并
铬烷酮。根据光谱数据和6e的X射线晶体结构,建立了合成的双螺并
铬烷酮。对所有合成的化合物进行了针对结核分枝 杆菌H37Rv(A
TCC 27294)菌株的评估,发现某些产品表现出良好的抗分枝杆菌活性,最低抑菌浓度低至\(3.125 \,\ upmu \ hbox g / mL} \)。进行了对接研究以鉴定化合物II的结合相互作用,FtsZ的6a和6n。使用HEK
细胞系进一步评估在
MTB MIC分析中表现出良好体外效价的化合物的毒性。 图形概要